Conditions: Asthma
Keywords: Asthma spirometry lung function serum cortisol serum potassium plasma glucose
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 28
Healthy volunteers: no

Brief summary:
This study will investigate the safety and tolerability of indacaterol maleate/mometasone furoate via the Twisthaler device after 14 days treatment in patients with mild to moderate asthma.

Detailed description:

Arms:
arm 1: Participants received 2 inhalations of indacaterol maleate / mometasone furoate 250/400 μg once daily in the evening (full dose 500/800 μg) delivered via the Twisthaler device for 14 days. arm 2: Participants received 2 inhalations of placebo to indacaterol maleate / mometasone furoate once daily in the evening delivered via the Twisthaler device for 14 days.

Interventions: intervention 1: indacaterol maleate / mometasone furoate intervention 2: placebo to indacaterol maleate/mometasone furoate
Intervention descriptions: intervention 1: Indacaterol maleate / mometasone furoate 250/400 μg, 2 puffs once daily delivered via the Twisthaler device. intervention 2: Placebo to indacaterol maleate/mometasone furoate delivered via the Twisthaler device.

Protocol document: